Sequence heterogeneity in human immunodeficiency virus type 1 nef in patients presenting with rapid progression and delayed progression to AIDS

Arch Virol. 2014 Sep;159(9):2303-20. doi: 10.1007/s00705-014-2026-2. Epub 2014 Apr 19.

Abstract

Genetic heterogeneity in the nef genes from human immunodeficiency virus type 1 (HIV-1)-infected rapid progressors (RPs) and long-term nonprogressors (LTNPs) was analyzed to identify various amino acid substitutions responsible for the discernible difference in disease progression. It was found that the majority of the strains characterized belonged to subtype C, followed by several BC recombinants and subtype A1. Complete nef subtype C sequences from 33 RPs and seven LTNPs were compared, and it was observed that, in the majority of the sequences from both groups, highly conserved functional motifs showed subtle changes. However, drastic changes were observed in two isolates from LTNPs where the arginine cluster was deleted, while in one of them, additionally, acidic residues were replaced by basic residues (EEEEE→RK(R)KKE). The deletion of the arginine cluster and the mutation of acidic residues to basic residues are predicted to delay disease development by abolishing CD4 downmodulation and causing diminution of major histocompatibility complex class I (MHC-I) downregulation, respectively. Nonetheless, this is an exclusive finding in these LTNPs, which necessitates their analysis at the functional level. The synonymous-to-nonsynonymous substitution ratio was greater than one in both of the groups, suggesting amino acid sequence conservation and functional robustness. Interpatient nucleotide distance within the group and between the two groups showed very little variation, confirming genetic relatedness among isolates.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / pathology*
  • Acquired Immunodeficiency Syndrome / virology*
  • Adult
  • Female
  • Genetic Variation*
  • HIV Long-Term Survivors
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation*
  • Sequence Analysis, DNA
  • Young Adult
  • nef Gene Products, Human Immunodeficiency Virus / genetics*
  • nef Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • nef Gene Products, Human Immunodeficiency Virus
  • nef protein, Human immunodeficiency virus 1

Associated data

  • GENBANK/JQ966772
  • GENBANK/JQ966773
  • GENBANK/JQ966774
  • GENBANK/JQ966775
  • GENBANK/JQ966776
  • GENBANK/JQ966777
  • GENBANK/JQ966778
  • GENBANK/JQ966779
  • GENBANK/JQ966780
  • GENBANK/JQ966781
  • GENBANK/JQ966782
  • GENBANK/JQ966783
  • GENBANK/JQ966784
  • GENBANK/JQ966785
  • GENBANK/JQ966786
  • GENBANK/JQ966787
  • GENBANK/JQ966788
  • GENBANK/JQ966789
  • GENBANK/JQ966790
  • GENBANK/JQ966791
  • GENBANK/JQ966792
  • GENBANK/JQ966793
  • GENBANK/JQ966794
  • GENBANK/JQ966795
  • GENBANK/JQ966796
  • GENBANK/JQ966797
  • GENBANK/JX294520
  • GENBANK/JX294521
  • GENBANK/JX294522
  • GENBANK/JX294523
  • GENBANK/JX294524
  • GENBANK/JX294525
  • GENBANK/JX294526
  • GENBANK/JX294527
  • GENBANK/JX294528
  • GENBANK/JX294529
  • GENBANK/JX294530
  • GENBANK/JX294531
  • GENBANK/JX294532
  • GENBANK/JX294533
  • GENBANK/JX294534
  • GENBANK/JX294535
  • GENBANK/JX294536
  • GENBANK/JX294537
  • GENBANK/JX294538
  • GENBANK/JX294539
  • GENBANK/JX294540
  • GENBANK/JX294541
  • GENBANK/JX294542
  • GENBANK/JX984611